Cargando…

How Strong Is the Evidence for Sodium Bicarbonate to Prevent Contrast-Induced Acute Kidney Injury After Coronary Angiography and Percutaneous Coronary Intervention?

Hydration with sodium bicarbonate is one of the strategies to prevent contrast-induced acute kidney injury (CI-AKI). The purpose of this study was to determine how strong is the evidence for sodium bicarbonate to prevent CI-AKI after coronary angiography (CAG) and/or percutaneous coronary interventi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Yuhao, Zhang, Bin, Liang, Long, Lian, Zhouyang, Liu, Jing, Liang, Changhong, Zhang, Shuixing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998610/
https://www.ncbi.nlm.nih.gov/pubmed/26886610
http://dx.doi.org/10.1097/MD.0000000000002715
_version_ 1782449971762561024
author Dong, Yuhao
Zhang, Bin
Liang, Long
Lian, Zhouyang
Liu, Jing
Liang, Changhong
Zhang, Shuixing
author_facet Dong, Yuhao
Zhang, Bin
Liang, Long
Lian, Zhouyang
Liu, Jing
Liang, Changhong
Zhang, Shuixing
author_sort Dong, Yuhao
collection PubMed
description Hydration with sodium bicarbonate is one of the strategies to prevent contrast-induced acute kidney injury (CI-AKI). The purpose of this study was to determine how strong is the evidence for sodium bicarbonate to prevent CI-AKI after coronary angiography (CAG) and/or percutaneous coronary intervention (PCI). We conducted PubMed, EMBASE, and CENTRAL databases to search for randomized controlled trials (RCTs) comparing the efficacy of sodium bicarbonate with sodium chloride to prevent CI-AKI after CAG and/or PCI. Relative risk (RR), standardized mean difference (SMD), or weighted mean difference (WMD) with 95% confidence intervals (CIs) was calculated. Heterogeneity, publication bias, and study quality were evaluated, sensitivity analyses, cumulative analyses, and subgroup analyses were performed. The risk of random errors was assessed by trial sequential analysis (TSA). Sixteen RCTs (3537 patients) met the eligibility criteria. Hydration with sodium bicarbonate showed significant beneficial effects in preventing CI-AKI (RR 0.67; 95% CI: 0.47–0.96, P = 0.029), decreasing the change in serum creatinine (SCr) (SMD −0.31 95% CI: −0.55 to −0.07, P = 0.011) and estimated glomerular filtration rate (eGFR) (SMD −0.17 95% CI: −0.30 to −0.04, P = 0.013). But no significant differences were observed in the requirement for dialysis (RR 1.11; 95% CI: 0.60–2.07, P = 0.729), mortality (RR 0.71; 95% CI: 0.41–1.21, P = 0.204) and reducing the length of hospital stay (LHS) (WMD −1.47; 95% CI: −4.14 to 1.20, P = 0.279). The result of TSA on incidence of CI-AKI showed the required information size (RIS = 6614) was not reached and cumulative z curve did not cross TSA boundary. The result of TSA on the requirement for dialysis and mortality demonstrated the required information sizes (RIS = 170,510 and 19,516, respectively) were not reached, and the cumulative z-curve did not cross any boundaries. The evidence that sodium bicarbonate reduces the incidence of CI-AKI is encouraging but more well-designed randomized controlled trails are required to allow definitive firm conclusion to be drawn.
format Online
Article
Text
id pubmed-4998610
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-49986102016-09-06 How Strong Is the Evidence for Sodium Bicarbonate to Prevent Contrast-Induced Acute Kidney Injury After Coronary Angiography and Percutaneous Coronary Intervention? Dong, Yuhao Zhang, Bin Liang, Long Lian, Zhouyang Liu, Jing Liang, Changhong Zhang, Shuixing Medicine (Baltimore) 6800 Hydration with sodium bicarbonate is one of the strategies to prevent contrast-induced acute kidney injury (CI-AKI). The purpose of this study was to determine how strong is the evidence for sodium bicarbonate to prevent CI-AKI after coronary angiography (CAG) and/or percutaneous coronary intervention (PCI). We conducted PubMed, EMBASE, and CENTRAL databases to search for randomized controlled trials (RCTs) comparing the efficacy of sodium bicarbonate with sodium chloride to prevent CI-AKI after CAG and/or PCI. Relative risk (RR), standardized mean difference (SMD), or weighted mean difference (WMD) with 95% confidence intervals (CIs) was calculated. Heterogeneity, publication bias, and study quality were evaluated, sensitivity analyses, cumulative analyses, and subgroup analyses were performed. The risk of random errors was assessed by trial sequential analysis (TSA). Sixteen RCTs (3537 patients) met the eligibility criteria. Hydration with sodium bicarbonate showed significant beneficial effects in preventing CI-AKI (RR 0.67; 95% CI: 0.47–0.96, P = 0.029), decreasing the change in serum creatinine (SCr) (SMD −0.31 95% CI: −0.55 to −0.07, P = 0.011) and estimated glomerular filtration rate (eGFR) (SMD −0.17 95% CI: −0.30 to −0.04, P = 0.013). But no significant differences were observed in the requirement for dialysis (RR 1.11; 95% CI: 0.60–2.07, P = 0.729), mortality (RR 0.71; 95% CI: 0.41–1.21, P = 0.204) and reducing the length of hospital stay (LHS) (WMD −1.47; 95% CI: −4.14 to 1.20, P = 0.279). The result of TSA on incidence of CI-AKI showed the required information size (RIS = 6614) was not reached and cumulative z curve did not cross TSA boundary. The result of TSA on the requirement for dialysis and mortality demonstrated the required information sizes (RIS = 170,510 and 19,516, respectively) were not reached, and the cumulative z-curve did not cross any boundaries. The evidence that sodium bicarbonate reduces the incidence of CI-AKI is encouraging but more well-designed randomized controlled trails are required to allow definitive firm conclusion to be drawn. Wolters Kluwer Health 2016-02-18 /pmc/articles/PMC4998610/ /pubmed/26886610 http://dx.doi.org/10.1097/MD.0000000000002715 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 6800
Dong, Yuhao
Zhang, Bin
Liang, Long
Lian, Zhouyang
Liu, Jing
Liang, Changhong
Zhang, Shuixing
How Strong Is the Evidence for Sodium Bicarbonate to Prevent Contrast-Induced Acute Kidney Injury After Coronary Angiography and Percutaneous Coronary Intervention?
title How Strong Is the Evidence for Sodium Bicarbonate to Prevent Contrast-Induced Acute Kidney Injury After Coronary Angiography and Percutaneous Coronary Intervention?
title_full How Strong Is the Evidence for Sodium Bicarbonate to Prevent Contrast-Induced Acute Kidney Injury After Coronary Angiography and Percutaneous Coronary Intervention?
title_fullStr How Strong Is the Evidence for Sodium Bicarbonate to Prevent Contrast-Induced Acute Kidney Injury After Coronary Angiography and Percutaneous Coronary Intervention?
title_full_unstemmed How Strong Is the Evidence for Sodium Bicarbonate to Prevent Contrast-Induced Acute Kidney Injury After Coronary Angiography and Percutaneous Coronary Intervention?
title_short How Strong Is the Evidence for Sodium Bicarbonate to Prevent Contrast-Induced Acute Kidney Injury After Coronary Angiography and Percutaneous Coronary Intervention?
title_sort how strong is the evidence for sodium bicarbonate to prevent contrast-induced acute kidney injury after coronary angiography and percutaneous coronary intervention?
topic 6800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998610/
https://www.ncbi.nlm.nih.gov/pubmed/26886610
http://dx.doi.org/10.1097/MD.0000000000002715
work_keys_str_mv AT dongyuhao howstrongistheevidenceforsodiumbicarbonatetopreventcontrastinducedacutekidneyinjuryaftercoronaryangiographyandpercutaneouscoronaryintervention
AT zhangbin howstrongistheevidenceforsodiumbicarbonatetopreventcontrastinducedacutekidneyinjuryaftercoronaryangiographyandpercutaneouscoronaryintervention
AT lianglong howstrongistheevidenceforsodiumbicarbonatetopreventcontrastinducedacutekidneyinjuryaftercoronaryangiographyandpercutaneouscoronaryintervention
AT lianzhouyang howstrongistheevidenceforsodiumbicarbonatetopreventcontrastinducedacutekidneyinjuryaftercoronaryangiographyandpercutaneouscoronaryintervention
AT liujing howstrongistheevidenceforsodiumbicarbonatetopreventcontrastinducedacutekidneyinjuryaftercoronaryangiographyandpercutaneouscoronaryintervention
AT liangchanghong howstrongistheevidenceforsodiumbicarbonatetopreventcontrastinducedacutekidneyinjuryaftercoronaryangiographyandpercutaneouscoronaryintervention
AT zhangshuixing howstrongistheevidenceforsodiumbicarbonatetopreventcontrastinducedacutekidneyinjuryaftercoronaryangiographyandpercutaneouscoronaryintervention